Company intelligence / Profile preview

Winnovart

Ownership: Private
Development stage: Other

Overview

Winnovart is an independent consultancy specializing in grants and funding advisory services for innovative small and medium-sized enterprises (SMEs) across Europe. The company focuses on helping clients access public funding programs such as the EIC Accelerator and EEA & Norway Grants. While Winnovart works with clients in life sciences/biotech/pharma/healthcare sectors by supporting their access to innovation funding, it does not itself develop therapeutics or medical technologies[1][2][6].

Industry: Consulting

Partnerships

No major pharmaceutical or biotech partnerships; collaborates with private investors and funding agencies to support client projects[1][2]

Beyond the preview

Go deeper on Winnovart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Winnovart.

Explore the full profile